Total Payments
$516,983
2024 Payments
$15,383
Companies
80
Transactions
1,034
Medicare Patients
6,230
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$363,169 (70.2%)
Consulting$82,541 (16.0%)
Travel$52,757 (10.2%)
Food & Beverage$18,252 (3.5%)
Education$264.74 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $361,919 | 170 | 70.0% |
| Consulting Fee | $82,541 | 39 | 16.0% |
| Travel and Lodging | $52,757 | 249 | 10.2% |
| Food and Beverage | $18,252 | 565 | 3.5% |
| Honoraria | $1,250 | 1 | 0.2% |
| Education | $264.74 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $135,022 | 203 | $0 (2024) |
| Amgen Inc. | $102,397 | 139 | $0 (2023) |
| Gilead Sciences, Inc. | $72,646 | 87 | $0 (2024) |
| Heron Therapeutics, Inc. | $58,918 | 60 | $0 (2024) |
| Seagen Inc. | $38,069 | 44 | $0 (2023) |
| Kite Pharma, Inc. | $23,003 | 27 | $0 (2023) |
| Coherus Biosciences Inc. | $15,238 | 22 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $14,443 | 64 | $0 (2024) |
| PFIZER INC. | $10,063 | 28 | $0 (2024) |
| Cardinal Health 414, LLC | $8,950 | 7 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,383 | 75 | PFIZER INC. ($9,743) |
| 2023 | $43,432 | 115 | Seagen Inc. ($27,160) |
| 2022 | $31,509 | 111 | Seagen Inc. ($9,759) |
| 2021 | $51,851 | 105 | Lilly USA, LLC ($22,907) |
| 2020 | $41,085 | 86 | Lilly USA, LLC ($18,446) |
| 2019 | $128,785 | 220 | Lilly USA, LLC ($86,809) |
| 2018 | $87,911 | 140 | Gilead Sciences, Inc. ($30,134) |
| 2017 | $117,028 | 182 | Amgen Inc. ($51,851) |
All Payment Transactions
1,034 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $2.02 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| Category: Hematology/Oncology | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $29.57 | General |
| 09/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Oncology | ||||||
| 09/14/2024 | EAGLE PHARMACEUTICALS, INC. | PEMFEXY (Drug) | Food and Beverage | In-kind items and services | $65.80 | General |
| Category: Oncology | ||||||
| 09/14/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $65.80 | General |
| Category: HEMATOLOGY | ||||||
| 09/12/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,540.00 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $45.08 | General |
| Category: HEMATOLOGY | ||||||
| 09/11/2024 | ASD Specialty Healthcare, LLC | — | Food and Beverage | In-kind items and services | $191.76 | General |
| 09/10/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: BioOncology | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.32 | General |
| 08/29/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: BioOncology | ||||||
| 08/28/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $21.75 | General |
| 08/12/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Oncology | ||||||
| 07/31/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/27/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.76 | General |
| 07/18/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,154 | 29,968 | $538,063 | $157,010 |
| 2022 | 35 | 1,468 | 4,681 | $495,216 | $141,704 |
| 2021 | 45 | 1,945 | 23,796 | $1.5M | $619,292 |
| 2020 | 40 | 1,663 | 12,897 | $649,988 | $235,628 |
Total Patients
6,230
Total Services
71,342
Medicare Billing
$1.2M
Procedure Codes
149
All Medicare Procedures & Services
149 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 327 | $94,830 | $30,831 | 32.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 144 | $48,240 | $19,760 | 41.0% |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | Office | 2023 | 12 | 3,400 | $35,700 | $19,408 | 54.4% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 15 | 7,080 | $65,632 | $16,508 | 25.2% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 15 | 15,750 | $39,375 | $13,767 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 194 | $36,860 | $12,896 | 35.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 23 | 88 | $42,944 | $9,386 | 21.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 216 | 702 | $38,610 | $5,254 | 13.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 156 | 416 | $27,040 | $4,239 | 15.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 28 | $12,012 | $4,054 | 33.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 48 | $7,920 | $3,173 | 40.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 30 | 57 | $13,110 | $3,035 | 23.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 201 | $13,668 | $2,320 | 17.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,940 | $2,033 | 34.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 17 | 86 | $11,610 | $2,006 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,460 | $1,703 | 31.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 43 | 112 | $8,344 | $1,496 | 17.9% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 17 | 141 | $5,640 | $1,285 | 22.8% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 20 | 39 | $3,900 | $724.62 | 18.6% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 12 | 52 | $4,420 | $627.70 | 14.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 15 | 31 | $2,883 | $510.26 | 17.7% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 39 | 77 | $3,696 | $446.84 | 12.1% |
| 83550 | Iron binding capacity | Office | 2023 | 27 | 52 | $1,820 | $445.64 | 24.5% |
| 83540 | Iron level | Office | 2023 | 27 | 52 | $2,600 | $329.68 | 12.7% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 14 | 26 | $1,690 | $275.86 | 16.3% |
About Dr. Gary Kay, M.D
Dr. Gary Kay, M.D is a Hematology & Oncology healthcare provider based in Elk Grove Village, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205897923.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Kay, M.D has received a total of $516,983 in payments from pharmaceutical and medical device companies, with $15,383 received in 2024. These payments were reported across 1,034 transactions from 80 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($361,919).
As a Medicare-enrolled provider, Kay has provided services to 6,230 Medicare beneficiaries, totaling 71,342 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 149 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Elk Grove Village, IL
- Active Since 03/31/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1205897923
Products in Payments
- VERZENIO (Drug) $121,459
- Vectibix (Biological) $73,695
- Zydelig (Drug) $72,255
- ADCETRIS (Biological) $47,682
- SUSTOL (Drug) $45,585
- Yescarta (Drug) $22,812
- XGEVA (Biological) $15,485
- Udenyca (Biological) $15,238
- PROMACTA (Drug) $13,701
- CINVANTI (Drug) $13,173
- Doptelet (Drug) $8,493
- Prolia (Biological) $4,831
- CARVYKTI (Drug) $1,680
- BESREMI (Drug) $1,616
- LIBTAYO (Biological) $1,598
- IMFINZI (Biological) $1,455
- TRODELVY (Drug) $1,400
- Oral Paclitaxel (Drug) $1,250
- REBLOZYL (Biological) $1,245
- Rubraca (Drug) $1,206
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Elk Grove Village
Dr. Gary Grad, M.d, M.D
Hematology & Oncology — Payments: $338,552
Hematology & Oncology $338,552
Dr. Alkarim Tajuddin, M.d, M.D
Hematology & Oncology — Payments: $44,272
Hematology & Oncology $44,272
Dr. Bruce Bank, M.d, M.D
Hematology & Oncology — Payments: $34,272
Hematology & Oncology $34,272
Dr. Ronald Shade, M.d, M.D
Hematology & Oncology — Payments: $32,380
Hematology & Oncology $32,380
Dr. Steven Kanter, M.d, M.D
Hematology & Oncology — Payments: $24,270
Hematology & Oncology $24,270
Dr. Gary Gordon, M.d, M.D
Hematology & Oncology — Payments: $22,948
Hematology & Oncology $22,948